Skip to content

Skeletal Muscle Response to Amino Acids and Load Carriage Exercise

Skeletal Muscle and Physical Performance Responses to Leucine-Enriched Nutrition Supplementation During Load Carriage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01714479
Enrollment
40
Registered
2012-10-26
Start date
2012-10-31
Completion date
2013-11-30
Last updated
2017-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Anabolism, Muscle Loss, Muscle Performance

Brief summary

Warfighters often experience physical overload, as the uniform and associated gear that they carry burdens them with substantial loads. The loads increase energy expenditure to levels that exceed a Warfighter's typical energy intake. The typical assault load is approximately 25 kg, although loads as high as 55 kg are often carried, which when combined with extreme energy expenditures can degrade health and performance, and increase the risk of injury. Branched-chain amino acid (leucine) supplementation may confer protection against the negative effects of operational stress by stimulating muscle protein synthesis and reducing degradation. This study will determine if leucine-enriched nutrition supplementation confers protection against the negative consequences of sustained load carriage exercise, and explore the mechanisms by which leucine might impart protection.

Interventions

OTHERLeucine-enriched nutritional supplement

A protein and carbohydrate supplement with high levels of leucine

OTHERPlacebo

Sponsors

US Army Natick Soldier Research, Development & Engineering Center
CollaboratorUNKNOWN
United States Army Research Institute of Environmental Medicine
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* Weight stable (±5 lbs)with a body mass index between 22-29 kg/m2 and a VO2peak of 40 - 60 ml/kg/min * Willing to refrain from taking any NSAIDS (i.e., aspirin, Advil®, Aleve®, Naprosyn®), or any aspirin-containing products, alchohol, and nicotine * Females must be on oral contraception

Exclusion criteria

* Metabolic or cardiovascular abnormalities, gastrointestinal disorders * Disease or medication that affects macronutrient metabolism or the ability to participate in strenuous exercise * Allergies or intolerance to foods (e.g. lactose intolerance/milk allergy), vegetarian practices, or medications (including, but not limited to, lidocaine or phenylalanine) to be used in the study * Anemia (HCT \<38) and Sickle Cell Anemia/Trait, abnormal PT/PTT test or problems with blood clotting * Present condition of alcoholism, use of nutritional/sports supplements, anabolic steroids, or other substance abuse issues * Musculoskeletal injuries that compromise the ability to exercise * Blood donation within 8 weeks of enrollment * Pregnancy and women not on oral contraceptives

Design outcomes

Primary

MeasureTime frame
Change in muscle protein synthesis and whole-body protein turnover during and after load carriage or conventional exercise with or without amino acid supplementation90 min exercise bout (exercise) and 180 min of recovery

Secondary

MeasureTime frame
Changes in muscle performance in recovery from load carriage or conventional exercise with or without amino acid supplementation4, 24, 48, and 72 hours post exercise

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026